 WALTHAM, Mass. , May 26, 2022 PRNewswire -- Syndax Pharmaceuticals, Inc. Syndax, the Company or we Nasdaq: SNDX, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in two upcoming investor conferences: A virtual fireside chat at Cowens 3rd Annual Oncology Innovation Summit at 12:30 p.m. 